Probably, these difference could be explained by the hypersensitivity of MPN stem/progenitor cells to cytokines and growth factors, and it is plausible that even low amounts of secreted IL-33 within the niche may be sufficient to start a ST2-dependent inflammation that favors MPNs. The gene discussed is IL33; the disease is myeloproliferative disorder.